Impact Story

CDER researchers have conducted a randomized study to better understand how physicians make prescribing decisions.As they make decisions about which drug products should be prescribed to their patients, physicians must process a great deal of relevant information in a...

Completed PDUFA VI Deliverables

Assessment in Support of Sentinel SystemPublic Report FDA’s assessment of the Sentinel system including the analysis and reporting of the impact of the Sentinel expansion and integration on FDA’s use of Sentinel for regulatory purposes. Enhancement and modernization...

QM CoE Educational Resources

Discover educational resources available under the QM CoE.FDA/C-Path Institute Model Informed Drug Development Web-Based Training The U.S. Food and Drug Administration’s (FDA’s) Center for Drug Evaluation and Research (CDER) Quantitative Medicine Center of Excellence...

Impact Story

CDER research is helping to inform how peptide and protein therapeutics that are not monoclonal antibodies should be regulated.Background and scientific challengeThe most common mechanism of drug-induced QT prolongation[1] and the associated rare, but potentially...